Litigation Details for Pfizer Inc. v. Aurobindo Pharma Limited (D. Del. 2023)
✉ Email this page to a colleague
Pfizer Inc. v. Aurobindo Pharma Limited (D. Del. 2023)
| Docket | 1:23-cv-01182 | Date Filed | 2023-10-19 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | Assigned To | Gregory B. Williams | |
| Jury Demand | Referred To | Christopher J. Burke | |
| Patents | 7,214,695; 7,214,696; 9,770,441 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Aurobindo Pharma Limited
Details for Pfizer Inc. v. Aurobindo Pharma Limited (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-10-19 | External link to document | |||
| 2023-10-19 | 13 | Letter | in adults. Plaintiffs have asserted U.S. Patents Nos. 7,214,695 (Dexcel and Aurobindo); 7,214,696 (Dexcel…for case dispositive motions with respect to U.S. Patent No. 9,770,441, which the parties reached Case 1 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
